Immunotherapy; Blood Cancer; Breast Cancer; Bladder Cancer; Cervical Cancer; Head & Neck Cancer; Anal Cancer; Pancreatic Cancer

Latest news and research on all cancers and treatments, updated several times a week

Click here to Survive Longer        Here for Anti-Cancer Program          My Story starts HERE

Here’s a Sample of My Raw Data -> In Excel -> Leaner (Excel) -> with dictionary

Click here to see how I do my statistical analyses

Cells identified that enhance tumor growth and suppress anti-cancer immune attack

"We've known for decades that cancer has harnessed the immune system to keep pumping out large numbers of mature and immature myeloid cells ...

Scientists identify white blood cells that tumors use to suppress disease-fighting immune system - News-Medical.net

A Lethal Tailor Outfits Cancer-Hunting T-Cells: How It Works

The T-cells are now primed to find cancer, acting like a magnet to pull the immune system into hand-to-hand combat with cancer cells circulating in the ...

European Committee Gives Positive Opinion on Celgene Blood-Cancer Drug

Revlimid is an oral drug used to treat multiple myeloma—a rare blood cancer characterized by tumors and the suppression of the immune system—in ...

Study: Inactivating polymorphism may influence progression of ovarian and luminal breast cancer

Recent research has found that interactions between these bacteria and the immune system are critical for providing important defenses against ...

Top 8 Highlights From SABCS 2014 
This slide show features some of the top highlights from the 2014 San Antonio Breast Cancer Symposium, including ovarian suppression in ER-positive breast tumors, tamoxifen for disease prevention, and immunotherapies for triple-negative breast cancer.

OncoGenex cancer drug reduces risk of death in metastatic bladder cancer(OGXI)

OncoGenex Pharmaceuticals (OGXI -3.5%) announces the results of a Phase 2 study assessing the efficacy of low (600 mg) and high (1000 mg) dose ...

OncoGenex Pharma (OGXI) Reports Phase 2 Borealis-1 Results - StreetInsider.com (subscription)

OncoGenex (OGXI) Borealis-1 Data an Important Validation for Apotorsen, Street Under ... -StreetInsider.com (subscription)

Gamifying Cancer Research Crowdsources the Race for the Cure

The puzzles and data for the initial version of the game are part of the search for cures to muscle-invasive bladder cancer and lung cancer.

Advaxis Completes $17 Million Financing

a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology. .. developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology. The Lm-LLO technology, using bioengineered live attenuated Listeria monocytogenes bacteria, is the only known cancer immunotherapy agent shown in preclinical studies to both generate cancer fighting T-cells directed against a cancer antigen and neutralize Tregs and myeloid-derived suppressor cells (MDSCs), that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Advaxis's lead Lm-LLO immunotherapy, ADXS-HPV, targets human papillomavirus (HPV)-associated cancers and is in clinical trials for three indications: Phase 2 in invasive cervical cancer, Phase 1/2 in head and neck cancer, and Phase 1/2 in anal cancer

Inovio begins human testing of cancer therapy

Inovio Pharmaceuticals Inc. initiated a phase-I clinical trial this week of its DNA-based immunotherapy in cancer patients. Phase-I studies are the first ...

Ebola crisis pushes NewLink into limelight

The NewLink therapy closest to being marketed is the cancer vaccine HyperAcute. A version that targets pancreatic cancer is in a Phase 3 trial, one of ...